| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |